By Devika Patel
Knoxville, Tenn., July 30 - Novogen Ltd. said it took in A$5.5 million in a private placement of stock.
The company sold the shares at A$1.22 apiece to El Coronado Holdings LLC.
Proceeds will be used to participate in a $10 million public offering conducted by Novogen's United States subsidiary, Marshall Edwards Inc.
Novogen is a biotechnology company based in Sydney, Australia.
| Issuer: | Novogen Ltd.
|
| Issue: | Ordinary stock
|
| Amount: | A$5.5 million
|
| Price: | A$1.22
|
| Warrants: | No
|
| Investor: | El Coronado Holdings LLC
|
| Settlement date: | July 30
|
| Stock symbol: | Australia: NRT
|
| Stock price: | A$1.095 at close July 30
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
